# Effect of Venlafaxine Versus Dosulepin in Pain Predominant Somatic Symptom Disorder

> **NCT06803485** · PHASE4 · RECRUITING · sponsor: **All India Institute of Medical Sciences, Bhubaneswar** · enrollment: 84 (estimated)

## Conditions studied

- Somatic Symptom Disorder (DSM-V)

## Interventions

- **DRUG:** Venlafaxine
- **DRUG:** Dosulepin

## Key facts

- **NCT ID:** NCT06803485
- **Lead sponsor:** All India Institute of Medical Sciences, Bhubaneswar
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-03-11
- **Primary completion:** 2026-08
- **Final completion:** 2026-11
- **Target enrollment:** 84 (ESTIMATED)
- **Last updated:** 2025-09-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06803485

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06803485, "Effect of Venlafaxine Versus Dosulepin in Pain Predominant Somatic Symptom Disorder". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06803485. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*